EMA's draft reflection paper promotes using patient experience data in drug regulation to enhance decision-making processes. Patient perspectives, such as quality of life, complement scientific data ...
The European Medicines Agency (EMA) has published a reflection paper discussing key considerations for single-arm clinical trials that are used as pivotal evidence in regulatory filings. A public ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback